Literature DB >> 29558370

Coexisting genomic aberrations associated with lymph node metastasis in breast cancer.

Li Bao1,2,3,4, Zhaoyang Qian2, Maria B Lyng1,3, Ling Wang5, Yuan Yu2, Ting Wang5, Xiuqing Zhang2, Huanming Yang2,3, Nils Brünner3,4, Jun Wang2,3, Henrik J Ditzel1,3,6,7.   

Abstract

Single cancer cell-sequencing studies currently use randomly selected cells, limiting correlations among genomic aberrations, morphology, and spatial localization. We laser-captured microdissected single cells from morphologically distinct areas of primary breast cancer and corresponding lymph node metastasis and performed whole-exome or deep-target sequencing of more than 100 such cells. Two major subclones coexisted in different areas of the primary tumor, and the lymph node metastasis originated from a minor subclone in the invasive front of the primary tumor, with additional copy number changes, including chr8q gain, but no additional point mutations in driver genes. Lack of metastasis-specific driver events led us to assess whether other clonal and subclonal genomic aberrations preexisting in primary tumors contribute to lymph node metastasis. Gene mutations and copy number variations analyzed in 5 breast cancer tissue sample sets revealed that copy number variations in several genomic regions, including areas within chr1p, chr8q, chr9p, chr12q, and chr20q, harboring several metastasis-associated genes, were consistently associated with lymph node metastasis. Moreover, clonal expansion was observed in an area of morphologically normal breast epithelia, likely driven by a driver mutation and a subsequent amplification in chr1q. Our study illuminates the molecular evolution of breast cancer and genomic aberrations contributing to metastases.

Entities:  

Keywords:  Breast cancer; Genetic variation; Genetics; Molecular genetics; Oncology

Mesh:

Year:  2018        PMID: 29558370      PMCID: PMC5983317          DOI: 10.1172/JCI97449

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  52 in total

1.  Anti-apoptotic proteins induce non-random genetic alterations that result in selecting breast cancer metastatic cells.

Authors:  Olga Méndez; Yolanda Fernández; Miguel A Peinado; Victor Moreno; Angels Sierra
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

Review 2.  Metastasis as an evolutionary process.

Authors:  Samra Turajlic; Charles Swanton
Journal:  Science       Date:  2016-04-08       Impact factor: 47.728

3.  Lung metastasis genes couple breast tumor size and metastatic spread.

Authors:  Andy J Minn; Gaorav P Gupta; David Padua; Paula Bos; Don X Nguyen; Dimitry Nuyten; Bas Kreike; Yi Zhang; Yixin Wang; Hemant Ishwaran; John A Foekens; Marc van de Vijver; Joan Massagué
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-09       Impact factor: 11.205

4.  Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin.

Authors:  Iñigo Martincorena; Amit Roshan; Moritz Gerstung; Peter Ellis; Peter Van Loo; Stuart McLaren; David C Wedge; Anthony Fullam; Ludmil B Alexandrov; Jose M Tubio; Lucy Stebbings; Andrew Menzies; Sara Widaa; Michael R Stratton; Philip H Jones; Peter J Campbell
Journal:  Science       Date:  2015-05-22       Impact factor: 47.728

5.  Signatures of post-zygotic structural genetic aberrations in the cells of histologically normal breast tissue that can predispose to sporadic breast cancer.

Authors:  Lars A Forsberg; Chiara Rasi; Gyula Pekar; Hanna Davies; Arkadiusz Piotrowski; Devin Absher; Hamid Reza Razzaghian; Aleksandra Ambicka; Krzysztof Halaszka; Marcin Przewoźnik; Anna Kruczak; Geeta Mandava; Saichand Pasupulati; Julia Hacker; K Reddy Prakash; Ravi Chandra Dasari; Joey Lau; Nelly Penagos-Tafurt; Helena M Olofsson; Gunilla Hallberg; Piotr Skotnicki; Jerzy Mituś; Jaroslaw Skokowski; Michal Jankowski; Ewa Śrutek; Wojciech Zegarski; Eva Tiensuu Janson; Janusz Ryś; Tibor Tot; Jan P Dumanski
Journal:  Genome Res       Date:  2015-10       Impact factor: 9.043

6.  Subclonal diversification of primary breast cancer revealed by multiregion sequencing.

Authors:  Lucy R Yates; Moritz Gerstung; Stian Knappskog; Christine Desmedt; Gunes Gundem; Peter Van Loo; Turid Aas; Ludmil B Alexandrov; Denis Larsimont; Helen Davies; Yilong Li; Young Seok Ju; Manasa Ramakrishna; Hans Kristian Haugland; Peer Kaare Lilleng; Serena Nik-Zainal; Stuart McLaren; Adam Butler; Sancha Martin; Dominic Glodzik; Andrew Menzies; Keiran Raine; Jonathan Hinton; David Jones; Laura J Mudie; Bing Jiang; Delphine Vincent; April Greene-Colozzi; Pierre-Yves Adnet; Aquila Fatima; Marion Maetens; Michail Ignatiadis; Michael R Stratton; Christos Sotiriou; Andrea L Richardson; Per Eystein Lønning; David C Wedge; Peter J Campbell
Journal:  Nat Med       Date:  2015-06-22       Impact factor: 53.440

7.  Evolution of metastasis revealed by mutational landscapes of chemically induced skin cancers.

Authors:  Melissa Q McCreery; Kyle D Halliwill; Douglas Chin; Reyno Delrosario; Gillian Hirst; Peter Vuong; Kuang-Yu Jen; James Hewinson; David J Adams; Allan Balmain
Journal:  Nat Med       Date:  2015-11-02       Impact factor: 53.440

8.  E-cadherin repression contributes to c-Myc-induced epithelial cell transformation.

Authors:  V H Cowling; M D Cole
Journal:  Oncogene       Date:  2006-12-04       Impact factor: 9.867

9.  Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults.

Authors:  Andrew L Young; Grant A Challen; Brenda M Birmann; Todd E Druley
Journal:  Nat Commun       Date:  2016-08-22       Impact factor: 14.919

10.  Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance.

Authors:  Kari R Fischer; Anna Durrans; Sharrell Lee; Jianting Sheng; Fuhai Li; Stephen T C Wong; Hyejin Choi; Tina El Rayes; Seongho Ryu; Juliane Troeger; Robert F Schwabe; Linda T Vahdat; Nasser K Altorki; Vivek Mittal; Dingcheng Gao
Journal:  Nature       Date:  2015-11-11       Impact factor: 49.962

View more
  10 in total

Review 1.  Lymph Nodes in Breast Cancer - What Can We Learn from Translational Research?

Authors:  Florentia Peintinger; Roland Reitsamer; Marjolein L Smidt; Thorsten Kühn; Cornelia Liedtke
Journal:  Breast Care (Basel)       Date:  2018-09-25       Impact factor: 2.860

2.  Analysis of Tumor Genomic Pathway Alterations Using Broad-Panel Next-Generation Sequencing in Surgically Resected Lung Adenocarcinoma.

Authors:  Jian Zhou; Francisco Sanchez-Vega; Raul Caso; Kay See Tan; Whitney S Brandt; Gregory D Jones; Shi Yan; Prasad S Adusumilli; Matthew Bott; James Huang; James M Isbell; Smita Sihag; Daniela Molena; Valerie W Rusch; Walid K Chatila; Natasha Rekhtman; Fan Yang; Marc Ladanyi; David B Solit; Michael F Berger; Nikolaus Schultz; David R Jones
Journal:  Clin Cancer Res       Date:  2019-08-27       Impact factor: 12.531

3.  Precision Combination Therapies Based on Recurrent Oncogenic Coalterations.

Authors:  Xubin Li; Elisabeth K Dowling; Gonghong Yan; Zeynep Dereli; Behnaz Bozorgui; Parisa Imanirad; Jacob H Elnaggar; Augustin Luna; David G Menter; Patrick G Pilié; Timothy A Yap; Scott Kopetz; Chris Sander; Anil Korkut
Journal:  Cancer Discov       Date:  2022-06-02       Impact factor: 38.272

4.  Clinical and genomic analyses of neuroendocrine neoplasms of the breast.

Authors:  Yani Wei; Xuexuan Ke; Jiaxiu Yu; Qiuyang Jing; Hong Bu; Xiangfei Zeng; Bing Wei
Journal:  Mod Pathol       Date:  2021-11-02       Impact factor: 7.842

5.  Genome profiles of pathologist-defined cell clusters by multiregional LCM and G&T-seq in one triple-negative breast cancer patient.

Authors:  Zhongyi Zhu; Weiwei Wang; Feng Lin; Tracy Jordan; Guibo Li; Sveta Silverman; Si Qiu; Anil Abraham Joy; Chao Chen; Deanna L Hockley; Xi Zhang; Qing Zhou; Lynne M Postovit; Xiuqing Zhang; Yong Hou; John R Mackey; Bo Li; Gane Ka-Shu Wong
Journal:  Cell Rep Med       Date:  2021-10-19

6.  Aurora Kinase A and Bcl-xL Inhibition Suppresses Metastasis in Triple-Negative Breast Cancer.

Authors:  Natascha Skov; Carla L Alves; Sidse Ehmsen; Henrik J Ditzel
Journal:  Int J Mol Sci       Date:  2022-09-02       Impact factor: 6.208

7.  Tracing Tumor Evolution in Sarcoma Reveals Clonal Origin of Advanced Metastasis.

Authors:  Yuning J Tang; Jianguo Huang; Hidetoshi Tsushima; Ga I Ban; Hongyuan Zhang; Kristianne M Oristian; Vijitha Puviindran; Nerissa Williams; Xiruo Ding; Jianhong Ou; Sin-Ho Jung; Chang-Lung Lee; Yiqun Jiao; Benny J Chen; David G Kirsch; Benjamin A Alman
Journal:  Cell Rep       Date:  2019-09-10       Impact factor: 9.423

8.  Discrepancy of Breast and Axillary Pathologic Complete Response and Outcomes in Different Subtypes of Node-positive Breast Cancer after Neoadjuvant Chemotherapy.

Authors:  Shin-Cheh Chen; Chi-Chang Yu; Hsien-Kun Chang; Yung-Chang Lin; Yung-Feng Lo; Shih-Che Shen; Wen-Lin Kuo; Hsiu-Pei Tsai; Hsu-Huan Chou; Chia-Hui Chu; Wen-Chi Shen; Ren-Chin Wu; Shir-Hwa Ueng; Yi-Ting Huang
Journal:  J Cancer       Date:  2021-07-06       Impact factor: 4.207

9.  Genome-wide 5-Hydroxymethylcytosine Profiling Analysis Identifies MAP7D1 as A Novel Regulator of Lymph Node Metastasis in Breast Cancer.

Authors:  Shuang-Ling Wu; Xiaoyi Zhang; Mengqi Chang; Changcai Huang; Jun Qian; Qing Li; Fang Yuan; Lihong Sun; Xinmiao Yu; Xinmiao Cui; Jiayi Jiang; Mengyao Cui; Ye Liu; Huan-Wen Wu; Zhi-Yong Liang; Xiaoyue Wang; Yamei Niu; Wei-Min Tong; Feng Jin
Journal:  Genomics Proteomics Bioinformatics       Date:  2021-03-11       Impact factor: 7.691

10.  MAGE-C3 promotes cancer metastasis by inducing epithelial-mesenchymal transition and immunosuppression in esophageal squamous cell carcinoma.

Authors:  Qingnan Wu; Weimin Zhang; Yan Wang; Qingjie Min; Hongyue Zhang; Dezuo Dong; Qimin Zhan
Journal:  Cancer Commun (Lond)       Date:  2021-08-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.